Hemant Surgical Industries Limited (BOM:543916)
India · Delayed Price · Currency is INR 468.25
+6.80 (1.47%)
At close: Sep 11, 2026
BOM:543916 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 181.91 | 80.41 | 98 | 76.37 | 46.14 |
Depreciation & Amortization | 15.36 | 14.26 | 10.26 | 8.5 | 7.49 |
Loss (Gain) From Sale of Assets | -10.4 | -1.78 | -0.14 | - | - |
Other Operating Activities | 34.25 | 34.43 | -4.11 | 27.97 | 26.65 |
Change in Accounts Receivable | -469.68 | 13.96 | -45.39 | -15.43 | -113.83 |
Change in Inventory | -159.14 | -214.39 | -62.44 | -19.64 | 19.94 |
Change in Accounts Payable | 323.32 | 143.62 | 4.19 | 30.6 | 79.95 |
Change in Other Net Operating Assets | -236.04 | -24.19 | -75.95 | -45.38 | 54.31 |
Operating Cash Flow | -320.42 | 46.31 | -75.58 | 63 | 120.64 |
Operating Cash Flow Growth | - | - | - | -47.78% | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -93.9 | -375.73 | -55.22 | -39.31 | -4.23 |
Sale of Property, Plant & Equipment | 72.6 | 22.41 | - | - | - |
Investment in Securities | 0.07 | 34.74 | -45.67 | 4.57 | 3.64 |
Other Investing Activities | -8.51 | 15.83 | 11.21 | 5.04 | 1.24 |
Investing Cash Flow | -29.75 | -302.76 | -89.68 | -29.71 | -0.54 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 392.7 | 42.09 | - | - | 15.16 |
Long-Term Debt Issued | - | 197.9 | 4.83 | - | - |
Total Debt Issued | 392.7 | 240 | 4.83 | - | 15.16 |
Long-Term Debt Repaid | -205.14 | - | - | -15.86 | -62.41 |
Total Debt Repaid | -205.14 | - | - | -15.86 | -62.41 |
Net Debt Issued (Repaid) | 187.57 | 240 | 4.83 | -15.86 | -47.26 |
Issuance of Common Stock | 545.15 | - | 217.02 | 28 | - |
Other Financing Activities | -39.66 | -21.49 | -9.45 | -19.13 | -29.75 |
Financing Cash Flow | 693.06 | 218.51 | 212.4 | -6.99 | -77.01 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | 0 |
Net Cash Flow | 342.9 | -37.94 | 47.14 | 26.31 | 43.09 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -414.32 | -329.42 | -130.8 | 23.69 | 116.41 |
Free Cash Flow Growth | - | - | - | -79.65% | - |
Free Cash Flow Margin | -17.87% | -30.89% | -12.38% | 2.17% | 11.24% |
Free Cash Flow Per Share | -34.04 | -31.55 | -13.15 | 3.18 | 22.61 |
Levered Free Cash Flow | -321.24 | -353.12 | -160.73 | -22.26 | 78.02 |
Unlevered Free Cash Flow | -296.44 | -338.92 | -154.82 | -11.71 | 88.07 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | - | 9.45 | 19.13 | 16.39 |
Cash Income Tax Paid | 43.92 | 19.27 | 32.17 | 25.34 | 3.48 |
Change in Working Capital | -541.53 | -81.01 | -179.59 | -49.84 | 40.37 |